Cleavage of β-catenin by calpain in prostate and mammary tumor cells

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7237-7240

  Rios Doria, Jonathan ^a   Kuefer, Rainer ^c   Ethier, Stephen P ^a   Day, Mark L ^a,b,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; IONOMYCIN; T CELL FACTOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPSY; BIOACCUMULATION; BREAST TUMOR; CELL STRAIN MCF 7; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE INSERTION; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; PROTEIN DOMAIN;

BETA CATENIN; BREAST NEOPLASMS; CALCIUM; CALPAIN; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; HUMANS; IONOMYCIN; MALE; MUTATION; PROSTATIC NEOPLASMS; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 5644271513     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1048     Document Type: Article

References (27)

1. Giles RH, van Es, JH, Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
2. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
3. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (Wash D C) 1997;275:1787-90.
4. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (Wash D C) 1997;275:1784-7.
5. Candidus S, Bischoff P, Becker KF, Hofler H. No evidence for mutations in the alpha-and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 1996;56:49-52.
6. Schlosshauer PW, Brown SA, Eisinger K, et al. APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis (Lond) 2000;21:1453-6.
7. Voeller HJ, Truica CI, Gelmann EP. Beta-catenin mutations in human prostate cancer. Cancer Res 1998;58:2520-3.
8. Lin SY, Xia W, Wang JC, et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000:97:4262-6.
9. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 2000;6:1891-5.
10. Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB. Cyclin DI expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998;35:95-101.
11. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT. Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991;117:144-50.
12. Rios-Doria J, Day KC, Kuefer R, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 2003;278:1372-9.
13. Ignatoski KM, Ethier SP. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat 1999;54:173-82.
14. Rubin MA, Putzi M, Mucci N, et al. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 2000;6:1038-45.
15. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature (Lond) 2001;412:822-6.
16. Barth AI, Pollack AL, Altschuler Y, Mostov KE, Nelson WJ. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J Cell Biol 1997;136:693-706.
17. Munemitsu S, Albert I, Rubinfeld B, Polakis P. Deletion of an amino-terminal sequence stabilizes beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol 1996;16:4088-94.
18. Kolligs FT, Hu G, Dang CV, Fearon ER. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol 1999;19:5696-706.
19. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (Wash D C) 1997; 275:1790-2.
20. Barth AI, Stewart DB, Nelson WJ. T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin. Proc Natl Acad Sci USA 1999;96:4947-52.
21. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 2001;153:555-68.
22. Michaelson JS, Leder P. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 2001;20:5093-99.
23. Miyoshi Y, Iwao K, Nagasawa Y, et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 1998;58:2524-7.
24. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 2000;19:498-504.
25. Li G, Iyengar R. Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta-catenin-regulated cell proliferation. Proc Natl Acad Sci USA 2002;99:13254-9.
26. Watanabe M, Kakiuchi H, Kato H, et al. APC gene mutations in human prostate cancer. Jpn J Clin Oncol 1996;26:77-81.
27. Chesire DR, Ewing CM, Gage WR, Isaacs WB. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis. Oncogene 2002;21:2679-94.